Cargando…
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer
INTRODUCTION: Aromatase inhibitors (AIs) are a vital component of estrogen receptor positive (ER+) breast cancer treatment. De novo and acquired resistance, however, is common. The aims of this study were to relate patterns of copy number aberrations to molecular and proliferative response to AIs, t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406016/ https://www.ncbi.nlm.nih.gov/pubmed/25888249 http://dx.doi.org/10.1186/s13058-015-0532-0 |